Early-stage prostate cancer treatment success

Embargoed until: Publicly released:

With more testing being done on asymptomatic men, prostate cancer has become one of the more commonly diagnosed cancers among New Zealand men, with over 3000 new cases in 2015. Of 950 men in Wellington who received a particular treatment - radioactive seeds implanted directly into the prostate gland - more than 90 per cent had their cancer cured and there were few side effects reported. The researchers say the treatment's success was similar to studies in North America and Europe and conclude it is highly-effective and low-impact for men with early-stage prostate cancer.

Journal/conference: New Zealand Medical Journal

Organisation/s: Victoria University of Wellington

Media Release

From: New Zealand Medical Association (NZMA)

Key points

951 Kiwi men with prostate cancer treated with brachytherapy (radioactive seeds)

Treated men had long term follow up to ensure relapses and side effects were picked up

90% of men had their cancer cured

Few side effects, and quick recovery, so treatment was low impact

Results achieved for Kiwi men equal to best reported on men in USA and Europe


This is one of the largest series of men with early stage prostate cancer treated with radioactive seed implantation reported anywhere in the world. The treatment has been shown to cure most men with only minor side effects, confirming its position as a front-line treatment option for men with such cancers. The results also confirm that the use of complex modern technology can sometimes lead to remarkable medical outcomes.

News for:

New Zealand

Media contact details for this story are only visible to registered journalists.